Gene · 6375
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bile acids as inflammatory mediators and modulators of intestinal permeability. | Front Immunol | 2022 | 36569849 | PubTator, text mining | PubMed |
| Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. | J Transl Med | 2022 | 36564797 | PubTator, text mining | PubMed |
| Nivolumab for malignant transformation of ovarian mature cystic teratoma. | Gynecol Oncol Rep | 2022 | 36560959 | PubTator, text mining | PubMed |
| Fighting Death for Living: Recent Advances in Molecular and Genetic Mechanisms Underlying Maize Lethal Necrosis Disease Resistance. | Viruses | 2022 | 36560769 | PubTator, text mining | PubMed |
| Diversity of Circulating NKT Cells in Defense against Carbapenem-Resistant Klebsiella Pneumoniae Infection. | J Pers Med | 2022 | 36556247 | PubTator, text mining | PubMed |
| Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironment. | Genome Biol | 2022 | 36550535 | PubTator, text mining | PubMed |
| Molecular signatures in the progression of COVID-19 severity. | Sci Rep | 2022 | 36543855 | PubTator, text mining | PubMed |
| ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma. | BMC Pulm Med | 2022 | 36539782 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. | Mol Med | 2022 | 36536281 | PubTator, text mining | PubMed |
| Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure. | Mol Cancer | 2022 | 36514045 | PubTator, text mining | PubMed |
| Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy. | Front Med (Lausanne) | 2022 | 36507530 | PubTator, text mining | PubMed |
| BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood αβ CD8+ T cells. | Oncoimmunology | 2022 | 36507091 | PubTator, text mining | PubMed |
| Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects. | Front Immunol | 2022 | 36505477 | PubTator, text mining | PubMed |
| Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation. | Front Immunol | 2022 | 36505452 | PubTator, text mining | PubMed |
| CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma. | J Int Med Res | 2022 | 36495170 | PubTator, text mining | PubMed |
| Predictive biomarkers of colon cancer immunotherapy: Present and future. | Front Immunol | 2022 | 36483562 | PubTator, text mining | PubMed |
| Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions. | Front Immunol | 2022 | 36479125 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of PB and BM NK cells from severe aplastic anaemia patients. | Clin Transl Med | 2022 | 36471484 | PubTator, text mining | PubMed |
| Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus. | Nat Commun | 2022 | 36470882 | PubTator, text mining | PubMed |
| Editorial: Insights in antigen presenting cell biology: 2021. | Front Immunol | 2022 | 36466849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6375/papers?page=31